The medications that are being prescribed for neurological disorders and TBI are largely unsuccessful. There are thousands of studies on treating the human brain with photobiomodulation (light therapy) transcranial penetration including  PTSD, early on set dementia, Alzheimer’s, Parkinson’s, multiple sclerosis, CTE and many neurological diseases.

The studies that have been done are showing great promise and as result, many doctors have added photobiomodulation to their practice. Harvard, Yale, Oxford, Stanford, MIT, and hundreds of other top universities have committed resources toward advancing the use of photobiomodulation on the human brain. 

Light therapy reaches the mitochondria of the cell and the neurons and the endothelium (blood vessel lining) which respond to the photons by releasing of nitric oxide which is often called the “miracle molecule”.

The resulting natural vasodilation increases blood flow reaching areas of the brain in need of oxygen and nutrients and inflammation levels also decrease.

Nitric oxide is a signaling molecule, which also upregulates the manufacture of various healing substances including beneficial enzymes in the area where it is applied to the body.

Adding a photobiomodulation brain care program to your practice may be exactly what some of your patients need and could dramatically benefit from.

According to the U.S. National Library of Medicine there are more than 600 neurologic diseases and Neurological disabilities. Annually, of the 1.2 million most frequently diagnosed adult-onset brain disorders, 51.3% and 21% are due to stroke and Alzheimer’s disease, respectively.

Each year, the total number of new episodes of Parkinson’s disease and traumatic brain injury equals the total number of epilepsy episodes (135 million).

These along with traumatic brain injuries are affecting millions of American and other than neurofeedback, the current modalities on the markets to treat these conditions are largely unsuccessful.